Clever Leaves Holdings Inc. (CLVR)
| Market Cap | 4.32M |
| Revenue (ttm) | 17.42M |
| Net Income (ttm) | -17.90M |
| Shares Out | 1.75M |
| EPS (ttm) | -11.42 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 35,295 |
| Open | 2.350 |
| Previous Close | 2.350 |
| Day's Range | 2.350 - 2.540 |
| 52-Week Range | 1.380 - 8.400 |
| Beta | 1.71 |
| Analysts | Hold |
| Price Target | 24.00 (+875.61%) |
| Earnings Date | May 28, 2024 |
About CLVR
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natur... [Read more]
Full Company ProfileFinancial Performance
In 2023, CLVR's revenue was $17.42 million, an increase of 6.14% compared to the previous year's $16.41 million. Losses were -$17.90 million, -72.95% less than in 2022.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for CLVR stock is "Hold" and the 12-month stock price forecast is $24.0.
News
Clever Leaves Announces Voluntary Delisting and SEC Deregistration
TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, today announced that ...
Clever Leaves Reports Fourth Quarter and Full Year 2023 Results
- 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue - - Drove Year-over-Year General and Administrative Expense Reductions of 26% in Q4 2023 and 24% for th...
High Growth: Top Pot Stocks Making Moves into March 2024
As the cannabis industry continues to flourish in the United States, investors are keenly watching the market for top-performing marijuana stocks. With the industry projected to reach a staggering $30...
Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia
TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced today that t...
Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)
Multinational operator has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products.
Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of Investors
SAN DIEGO--(BUSINESS WIRE)---- $CLVR #CleverLeavesHoldingsInc--Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of Investors.
Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of Shareholder
SAN DIEGO--(BUSINESS WIRE)---- $CLVR #CleverLeavesHoldingsInc--Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of Shareholder.
Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
NEW YORK--(BUSINESS WIRE)---- $CLVR #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schultze Special Purpose Acquisi...
Clever Leaves Reports Third Quarter 2023 Results
- Q3 Revenue Increased 33% Year-Over-Year, Propelled by 135% Year-Over-Year Growth in Cannabinoid Revenue, Along with 6% Year-Over-Year Growth in Non-Cannabinoid Revenue -
Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ET
TOCANCIPÁ, Colombia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, will hold a conference...
Schultze Special Purpose Acquisition Corp. II Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
Rye Brook, New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. II (Nasdaq: SAMA) (the “Company”) today announced that it will redeem all of the outstanding shares o...
Clever Leaves Regains Compliance with Nasdaq Minimum Bid Price Requirement
TOCANCIPÁ, Colombia, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that it rec...
Clever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis Company
The CO2 Neutrality Certification Reflects Clever Leaves' Commitment to Environmental Sustainability and long-term vision for the cannabis industry.
Clever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements
TOCANCIPÁ, Colombia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that its Boa...
Clever Leaves Reports Second Quarter 2023 Results
- Total Revenue Increased 21% Year-Over-Year, Driven by 151% Year-Over-Year Growth in Cannabinoid Revenue - - Continued Expense Reductions Drive Improved Adjusted EBITDA Performance of ($2.1) Million ...
3 Top Marijuana Stocks To Watch Before The Weekend
Many cannabis companies are starting to release earnings this month. With strong earnings, some marijuana stocks could soon see a rise in momentum. At times when one or more companies report strong fi...
Clever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 p.m. ET
TOCANCIPÁ, Colombia, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, will hold a conference...
Colombian Flower Is Now Available To Australian Patients Through Strategic Partnership Between Clever Leaves And Australian Natural Therapeutics Group
TOCANCIPÁ, Colombia and SYDNEY, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, ...
3 Marijuana Stocks For Cannabis Investing The Rest Of The Month
The progress of the cannabis industry has contributed to more people looking to invest. But how will people know which marijuana stock to buy? This can be answered in several ways Initially you would ...
Clever Leaves Completes Sale of Processing Assets in Portugal to Curaleaf International Subsidiary
- Sale Marks Key Milestone of the Company's Wind-Down Process in Portugal and Provides Non-Dilutive Capital - - Sale Marks Key Milestone of the Company's Wind-Down Process in Portugal and Provides Non...
3 Marijuana Stocks To Buy For Cannabis Investment Options?
When looking for the best marijuana stocks to buy it is important to note that investing in the cannabis sector carries risks. The cannabis industry is relatively new and evolving. Currently, this com...
Clever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland
TOCANCIPÁ, Colombia, May 30, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”), a global medicinal cannabis company, announced today the arrival of the compa...
Clever Leaves Reminds Shareholders of its Upcoming Annual Meeting on June 2, 2023
TOCANCIPÁ, Colombia, May 26, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, reminds shareholders th...
Top Marijuana Stocks To Watch In The Global Cannabis Market
If you want to buy the top marijuana stocks today, you should be prepared to deal with extreme volatility. There are plenty of headlines to grapple with, whether it's the latest debt ceiling issue, Fe...
Clever Leaves Partners with SOMAÍ Pharmaceuticals and Sends First Commercial Shipments to Portugal
Multinational operator to supply pharmaceutical-grade CBD extract for European patients Multinational operator to supply pharmaceutical-grade CBD extract for European patients